A survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern Europe

Tamás Palotai, Jacek C. Szepietowski, Jurai Pec, Petr Arenberger, Calin Giurcaneanu, R. Gyulai, Jovan Miljkovic, Ene Pärna, Ingmars Mikazans, Nauris Grusauskas, Michal Hodik

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Because data on the epidemiology of psoriasis in central and eastern Europe are scarce, a survey was carried out among dermatologists in the Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Romania, Slovakia, and Slovenia. The objective of the survey was to determine disease severity, treatment patterns, proportions of dermatologists considering their patients' current treatments unsatisfactory, and proportions of physicians intending to prescribe biologicals to their patients. Data collection was based on physicianand patientcompleted questionnaires. Data on 913 patients were available. The mean age at onset of psoriasis was 29±15 years, mean proportion of affected body surface area 29%±22%, mean Psoriasis Area and Severity Index (PASI) 15±12, and mean Dermatology Life Quality Index (DLQI) 11±7. Overall, 37% of patients had severe disease defined as a PASI of 10 or more and a DLQI above 10; 45% of all patients and 58% of patients with severe disease had received standard systemics. In 53% of cases, dermatologists were dissatisfied with their patients' treatments. In almost all of these patients, physicians considered switching treatments, and in 65% of these patients, or more than 30% of the entire patient sample, physicians considered switching to biologicals, suggesting that nonbiologic treatment options in this group had been exhausted. Significant between-country differences were found for most study parameters. This survey was the first to assess the profile of patients with psoriasis in countries of central and eastern Europe. Psoriasis has a substantial impact on the quality of life, regardless of disease severity. More than one third of patients had severe disease, more than half of patients were considered by their physicians to be receiving inappropriate treatment, and in more than one third of patients physicians intended to switch to biologicals.

Original languageEnglish
Pages (from-to)151-162
Number of pages12
JournalActa Dermatovenerologica Croatica
Volume18
Issue number3
Publication statusPublished - 2010

Fingerprint

Eastern Europe
Psoriasis
Quality of Life
Therapeutics
Physicians
Dermatology
Surveys and Questionnaires
Latvia
Estonia
Lithuania
Slovenia
Romania
Slovakia
Hungary
Czech Republic
Body Surface Area
Poland
Age of Onset

Keywords

  • Anti-TNF therapy
  • Biologicals
  • Disease severity
  • Patient profile
  • Psoriasis
  • Quality of life
  • TNF-alpha inhibitors

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Cite this

A survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern Europe. / Palotai, Tamás; Szepietowski, Jacek C.; Pec, Jurai; Arenberger, Petr; Giurcaneanu, Calin; Gyulai, R.; Miljkovic, Jovan; Pärna, Ene; Mikazans, Ingmars; Grusauskas, Nauris; Hodik, Michal.

In: Acta Dermatovenerologica Croatica, Vol. 18, No. 3, 2010, p. 151-162.

Research output: Contribution to journalArticle

Palotai, T, Szepietowski, JC, Pec, J, Arenberger, P, Giurcaneanu, C, Gyulai, R, Miljkovic, J, Pärna, E, Mikazans, I, Grusauskas, N & Hodik, M 2010, 'A survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern Europe', Acta Dermatovenerologica Croatica, vol. 18, no. 3, pp. 151-162.
Palotai, Tamás ; Szepietowski, Jacek C. ; Pec, Jurai ; Arenberger, Petr ; Giurcaneanu, Calin ; Gyulai, R. ; Miljkovic, Jovan ; Pärna, Ene ; Mikazans, Ingmars ; Grusauskas, Nauris ; Hodik, Michal. / A survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern Europe. In: Acta Dermatovenerologica Croatica. 2010 ; Vol. 18, No. 3. pp. 151-162.
@article{feedae04a0f44ab9b8214b8404d210b9,
title = "A survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern Europe",
abstract = "Because data on the epidemiology of psoriasis in central and eastern Europe are scarce, a survey was carried out among dermatologists in the Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Romania, Slovakia, and Slovenia. The objective of the survey was to determine disease severity, treatment patterns, proportions of dermatologists considering their patients' current treatments unsatisfactory, and proportions of physicians intending to prescribe biologicals to their patients. Data collection was based on physicianand patientcompleted questionnaires. Data on 913 patients were available. The mean age at onset of psoriasis was 29±15 years, mean proportion of affected body surface area 29{\%}±22{\%}, mean Psoriasis Area and Severity Index (PASI) 15±12, and mean Dermatology Life Quality Index (DLQI) 11±7. Overall, 37{\%} of patients had severe disease defined as a PASI of 10 or more and a DLQI above 10; 45{\%} of all patients and 58{\%} of patients with severe disease had received standard systemics. In 53{\%} of cases, dermatologists were dissatisfied with their patients' treatments. In almost all of these patients, physicians considered switching treatments, and in 65{\%} of these patients, or more than 30{\%} of the entire patient sample, physicians considered switching to biologicals, suggesting that nonbiologic treatment options in this group had been exhausted. Significant between-country differences were found for most study parameters. This survey was the first to assess the profile of patients with psoriasis in countries of central and eastern Europe. Psoriasis has a substantial impact on the quality of life, regardless of disease severity. More than one third of patients had severe disease, more than half of patients were considered by their physicians to be receiving inappropriate treatment, and in more than one third of patients physicians intended to switch to biologicals.",
keywords = "Anti-TNF therapy, Biologicals, Disease severity, Patient profile, Psoriasis, Quality of life, TNF-alpha inhibitors",
author = "Tam{\'a}s Palotai and Szepietowski, {Jacek C.} and Jurai Pec and Petr Arenberger and Calin Giurcaneanu and R. Gyulai and Jovan Miljkovic and Ene P{\"a}rna and Ingmars Mikazans and Nauris Grusauskas and Michal Hodik",
year = "2010",
language = "English",
volume = "18",
pages = "151--162",
journal = "Acta Dermatovenerologica Croatica",
issn = "1330-027X",
publisher = "Croatian Dermatovenerological Society",
number = "3",

}

TY - JOUR

T1 - A survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern Europe

AU - Palotai, Tamás

AU - Szepietowski, Jacek C.

AU - Pec, Jurai

AU - Arenberger, Petr

AU - Giurcaneanu, Calin

AU - Gyulai, R.

AU - Miljkovic, Jovan

AU - Pärna, Ene

AU - Mikazans, Ingmars

AU - Grusauskas, Nauris

AU - Hodik, Michal

PY - 2010

Y1 - 2010

N2 - Because data on the epidemiology of psoriasis in central and eastern Europe are scarce, a survey was carried out among dermatologists in the Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Romania, Slovakia, and Slovenia. The objective of the survey was to determine disease severity, treatment patterns, proportions of dermatologists considering their patients' current treatments unsatisfactory, and proportions of physicians intending to prescribe biologicals to their patients. Data collection was based on physicianand patientcompleted questionnaires. Data on 913 patients were available. The mean age at onset of psoriasis was 29±15 years, mean proportion of affected body surface area 29%±22%, mean Psoriasis Area and Severity Index (PASI) 15±12, and mean Dermatology Life Quality Index (DLQI) 11±7. Overall, 37% of patients had severe disease defined as a PASI of 10 or more and a DLQI above 10; 45% of all patients and 58% of patients with severe disease had received standard systemics. In 53% of cases, dermatologists were dissatisfied with their patients' treatments. In almost all of these patients, physicians considered switching treatments, and in 65% of these patients, or more than 30% of the entire patient sample, physicians considered switching to biologicals, suggesting that nonbiologic treatment options in this group had been exhausted. Significant between-country differences were found for most study parameters. This survey was the first to assess the profile of patients with psoriasis in countries of central and eastern Europe. Psoriasis has a substantial impact on the quality of life, regardless of disease severity. More than one third of patients had severe disease, more than half of patients were considered by their physicians to be receiving inappropriate treatment, and in more than one third of patients physicians intended to switch to biologicals.

AB - Because data on the epidemiology of psoriasis in central and eastern Europe are scarce, a survey was carried out among dermatologists in the Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Romania, Slovakia, and Slovenia. The objective of the survey was to determine disease severity, treatment patterns, proportions of dermatologists considering their patients' current treatments unsatisfactory, and proportions of physicians intending to prescribe biologicals to their patients. Data collection was based on physicianand patientcompleted questionnaires. Data on 913 patients were available. The mean age at onset of psoriasis was 29±15 years, mean proportion of affected body surface area 29%±22%, mean Psoriasis Area and Severity Index (PASI) 15±12, and mean Dermatology Life Quality Index (DLQI) 11±7. Overall, 37% of patients had severe disease defined as a PASI of 10 or more and a DLQI above 10; 45% of all patients and 58% of patients with severe disease had received standard systemics. In 53% of cases, dermatologists were dissatisfied with their patients' treatments. In almost all of these patients, physicians considered switching treatments, and in 65% of these patients, or more than 30% of the entire patient sample, physicians considered switching to biologicals, suggesting that nonbiologic treatment options in this group had been exhausted. Significant between-country differences were found for most study parameters. This survey was the first to assess the profile of patients with psoriasis in countries of central and eastern Europe. Psoriasis has a substantial impact on the quality of life, regardless of disease severity. More than one third of patients had severe disease, more than half of patients were considered by their physicians to be receiving inappropriate treatment, and in more than one third of patients physicians intended to switch to biologicals.

KW - Anti-TNF therapy

KW - Biologicals

KW - Disease severity

KW - Patient profile

KW - Psoriasis

KW - Quality of life

KW - TNF-alpha inhibitors

UR - http://www.scopus.com/inward/record.url?scp=78149313141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149313141&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 151

EP - 162

JO - Acta Dermatovenerologica Croatica

JF - Acta Dermatovenerologica Croatica

SN - 1330-027X

IS - 3

ER -